SCHEMBL233264

SCHEMBL233264

O=CC(Br)Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.50
TAAR1 Q96RJ0 3/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
CYP1A2 P05177 1/20 0.45
LAP3 P28838 3/20 0.44
ANPEP P15144 1/20 0.44
ALPI P09923 1/20 0.42
PKM P14618 1/20 0.42
PTGS1 P23219 1/20 0.42
XIAP P98170 1/20 0.42
SLC7A5 Q01650 1/20 0.42
CAPN1 P07384 2/20 0.41
SLC6A2 P23975 2/20 0.41
MAOA P21397 1/20 0.41
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
CYP2A6 P11509 1/20 0.41
ADORA2A P29274 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4600642 0.83 BCHE (0.54) CYP1A2LAP3PTGS1SLC6A2MAOA
SCHEMBL7599594 0.81 TAAR1 (0.47) EPHX1TAAR1MEN1KMT2ASLC6A2
SCHEMBL20504575 0.80 MME (0.41) TAAR1CYP2A6
SCHEMBL6239697 0.79 EPHX1 (0.57) EPHX1TAAR1MEN1KMT2ACYP1A2
SCHEMBL3051234 0.78 SLC7A5 (0.46) TAAR1MEN1KMT2ACYP1A2SLC7A5
SCHEMBL754753 0.78 TRPA1 (0.41) TAAR1MAOA
SCHEMBL13754990 0.78 ACE (0.45) MEN1KMT2ACYP1A2ANPEPACE
SCHEMBL10299126 0.78 PPARG (0.38)
SCHEMBL5949739 0.78 TAAR1 (0.44) TAAR1CYP1A2MAOASIGMAR1
SCHEMBL4952292 0.77 EPHX1 (0.44) EPHX1TAAR1MEN1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015193910-A1 ASYMMETRIC SYNTHESIS OF 2-SUBSTITUTED INDOLINES AND 3-SUBSTITUTED CINNOLINES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-12-23 WO claimed
CN-101898944-B Method for preparing alpha-bromo-cinnamaldehyde WUHAN INST TECHNOLOGY 2013-06-19 CN claimed
CN-101898944-A Method for preparing alpha-bromo-cinnamaldehyde WUHAN INST TECHNOLOGY 2010-12-01 CN claimed
WO-2025091123-A1 MESOIONIC CARBENES QUEEN'S UNIVERSITY AT KINGSTON (CA) 2025-05-08 WO disclosed
CN-114989173-B Imidazole compound, pharmaceutical composition and application thereof 广州市恒诺康医药科技有限公司 2024-03-19 CN disclosed
EP-3568390-B1 SMALL MOLECULE ACTIVATORS OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) AND USES THEREOF SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST (US) 2024-03-06 EP disclosed
US-11806337-B2 Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof Sanford Burnham Prebys Medical Discovery Institute (US) 2023-11-07 US disclosed
US-11806337-B2 Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof Sanford Burnham Prebys Medical Discovery Institute (US) 2023-11-07 US disclosed
US-11806337-B2 Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof Sanford Burnham Prebys Medical Discovery Institute (US) 2023-11-07 US disclosed
US-20230116770-A1 SMALL MOLECULE ACTIVATORS OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) AND USES THEREOF Sanford Burnham Prebys Medical Discovery Institute 2023-04-13 US disclosed
US-11452717-B2 Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof Sanford Burnham Prebys Medical Discovery Institute (US) 2022-09-27 US disclosed
US-5849261-A Radiolabeled vasoactive intestinal peptides for diagnosis and therapy DIATIDE, INC. (US) 1998-12-15 US disclosed
WO-1998049196-A1 CALCITONIN RECEPTOR-BINDING PEPTIDES DIATIDE, INC. (US) 1998-11-05 WO disclosed
EP-0820313-A2 RADIOLABELED PEPTIDES FOR DIAGNOSIS AND THERAPY Diatide, Inc. (US) 1998-01-28 EP disclosed
EP-0804481-A1 SOMATOSTATIN DERIVATIVES AND THEIR RADIOLABELLED PRODUCTS Diatide, Inc. (US) 1997-11-05 EP disclosed
EP-0775160-A1 CYCLIC HEXAPEPTIDE SOMATOSTATIN ANALOGUES DIATECH, INC. (US) 1997-05-28 EP disclosed
US-5620675-A MEDICAL DIAGNOSIS DIATECH, INC. (US) 1997-04-15 US disclosed
WO-1996030055-A2 RADIOLABELED PEPTIDES FOR DIAGNOSIS AND THERAPY DIATIDE, INC. (US) 1996-10-03 WO disclosed
WO-1996004308-A1 CYCLIC HEXAPEPTIDE SOMATOSTATIN ANALOGUES DIATECH, INC. (US) 1996-02-15 WO disclosed
WO-1995003330-A1 SOMATOSTATIN DERIVATIVES AND THEIR RADIOLABELLED PRODUCTS DIATECH, INC. (US) 1995-02-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11452717-B2 Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof NAMPT, NAPRT, NNT EPHX1 3475/4885TAAR1 4669/4885MEN1 2154/4885
US-11806337-B2 Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof NAMPT, NAPRT, NNT EPHX1 3475/4885TAAR1 4669/4885MEN1 2154/4885
US-20230116770-A1 SMALL MOLECULE ACTIVATORS OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) AND USES THEREOF NAMPT, NAPRT, NNT EPHX1 3475/4885TAAR1 4669/4885MEN1 2154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.